Learn more about launching predictive biomarker-driven therapies and overcoming complexities in global markets with Discovery Life Sciences. In this webinar video, Gudrun Baenfer, PhD, Client Relations and Business Expansion Manager, Peri and Post Approval Services, will discuss actionable strategies for pharmaceutical professionals in Medical Affairs, Diagnostics, Precision Medicine, and Commercialization, including:
- Scientific Validation and Evidence Generation: Ensuring biomarker test reliability and reproducibility for informed clinical decision-making and effective therapy adoption.
- Market Access Strategies: Expanding global reach by onboarding Key Opinion Leaders (KOLs), designing early access programs, and enabling labs for biomarker testing.
- Collaboration Between Stakeholders: Understanding partnerships between treating physicians and pathologists to ensure accurate result reporting and deliver the right therapy to the right patients.
- Overcoming Diagnostic Challenges: Navigating scenarios where a companion diagnostic (CDx) is unavailable, relying on lab-developed tests.